Histone methyltransferase and histone methylation in inflammatory T-cell responses

Immunotherapy

Volumn 5, Issue 9, 2013, Pages 989-1004

  He, Shan ^a   Tong, Qing ^a,b   Bishop, Dennis Keith ^c   Zhang, Yi ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

differentiation; effector T cell; epigenetic effects; histone methyltranferase; memory cell maintenance

Indexed keywords

HISTONE METHYLTRANSFERASE; INTERLEUKIN 12; INTERLEUKIN 21; INTERLEUKIN 5; INTERLEUKIN 6; MIXED LINEAGE LEUKEMIA PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; STAT6 PROTEIN; TRANSCRIPTION FACTOR EZH2; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET;

3' UNTRANSLATED REGION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL SURVIVAL; CELLULAR IMMUNITY; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOME SEGREGATION; CYTOKINE PRODUCTION; EFFECTOR CELL; GENE EXPRESSION; GENE LOCUS; GRAFT VERSUS HOST REACTION; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; IMMUNE RESPONSE; MEMORY T LYMPHOCYTE; NONHUMAN; PHENOTYPE; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROCESSING; RESPIRATORY TRACT INFLAMMATION; REVIEW; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; TRANSCRIPTION REGULATION;

ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC;

EID: 84883590758     PISSN: 1750743X     EISSN: 17507448     Source Type: Journal    
DOI: 10.2217/imt.13.101     Document Type: Review

References (140)

1. Wherry EJ, Ha SJ, Kaech SM et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27, 670-684 (2007).
2. Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26, 677-704 (2008).
3. Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat. Rev. Cancer 8, 299-308 (2008).
4. Heslop HE. How I treat EBV lymphoproliferation. Blood 114, 4002-4008 (2009).
5. Teshima T, Maeda Y, Ozaki K. Regulatory T cells and IL-17-producing cells in graft-versus-host disease. Immunotherapy 3, 833-852 (2011).
6. Zhang N, Bevan MJ. CD8(+) T cells: foot soldiers of the immune system. Immunity 35, 161-168 (2011).
7. Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus-host disease biology and therapy. Nat. Rev. Immunol. 12, 443-458 (2012).
8. Kaech SM, Cui W. Transcriptional control of effector and memory CD8+ T cell differentiation. Nat. Rev. Immunol. 12, 749-761 (2012).
9. Restifo NP, Dudley ME, Rosenberg SA. Adoptive immunotherapy for cancer: harnessing the T cell response. Nat. Rev. Immunol. 12, 269-281 (2012).
10. Fearon DT. The expansion and maintenance of antigen-selected CD8(+) T cell clones. Adv. Immunol. 96, 103-139 (2007).
11. Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations (*). Annu. Rev. Immunol. 28, 445-489 (2010).
12. Amsen D, Antov A, Flavell RA. The different faces of Notch in T-helper-cell differentiation. Nat. Rev. Immunol. 9, 116-124 (2009).
13. Zhou L, Chong MM, Littman DR. Plasticity of CD4+ T cell lineage differentiation. Immunity 30, 646-655 (2009).
14. Wilson CB, Rowell E, Sekimata M. Epigenetic control of T-helper-cell differentiation. Nat. Rev. Immunol. 9, 91-105 (2009).
15. Strahl BD, Allis CD. The language of covalent histone modifications. Nature 403, 41-45 (2000).
16. Jenuwein T, Allis CD. Translating the histone code. Science 293, 1074-1080 (2001).
17. Ellis L, Atadja PW, Johnstone RW. Epigenetics in cancer: targeting chromatin modifications. Mol. Cancer Ther. 8, 1409-1420 (2009).
18. Badeaux AI, Shi Y. Emerging roles for chromatin as a signal integration and storage platform. Nat. Rev. Mol. Cell Biol. 14, 211-224 (2013).
19. Wu JI, Lessard J, Crabtree GR. Understanding the words of chromatin regulation. Cell 136, 200-206 (2009).
20. Kouzarides T. Chromatin modifications and their function. Cell 128, 693-705 (2007).
21. Kelly TK, De Carvalho DD, Jones PA. Epigenetic modifications as therapeutic targets. Nat. Biotechnol. 28, 1069-1078.
22. Kimura M et al. Regulation of Th 2 cell differentiation by mel-18, a mammalian polycomb group gene. Immunity 15, 275-287 (2001).
23. Yamashita M et al. Interleukin (IL)-4-independent maintenance of histone modification of the IL-4 gene loci in memory Th 2 cells. J. Biol. Chem. 279, 39454-39464 (2004).
24. Koyanagi M et al. EZH2 and histone 3 trimethyl lysine 27 associated with IL 4 and IL 13 gene silencing in Th 1 cells. J. Biol. Chem. 280, 31470-31477 (2005).
25. Yamashita M, Hirahara K, Shinnakasu R et al. Crucial role of MLL for the maintenance of memory T helper type 2 cell responses. Immunity 24, 611-622 (2006).
26. Chang S, Aune TM. Dynamic changes in histone-methylation 'marks' across the locus encoding interferon-gamma during the differentiation of T helper type 2 cells. Nat. Immunol. 8, 723-731 (2007).
27. Jacob E, Hod-Dvorai R, Schif-Zuck S, Avni O. Unconventional association of the polycomb group proteins with cytokine genes in differentiated T helper cells. J. Biol. Chem. 283, 13471-13481 (2008).
28. Northrop JK, Wells AD, Shen H. Cutting edge: chromatin remodeling as a molecular basis for the enhanced functionality of memory CD8 T cells. J. Immunol. 181, 865-868 (2008).
29. Yamashita M, Kuwahara M, Suzuki A et al. Bmi 1 regulates memory CD4 T cell survival via repression of the Noxa gene. J. Exp. Med. 205, 1109-1120 (2008).
30. Juelich T, Sutcliffe EL, Denton A et al. Interplay between chromatin remodeling and epigenetic changes during lineage-specific commitment to granzyme B expression. J. Immunol. 183, 7063-7072 (2009).
31. Wei G, Wei L, Zhu J et al. Global mapping of H3K4me 3 and H3K27me 3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 30, 155-167 (2009).
32. Roh TY, Cuddapah S, Cui K, Zhao K. The genomic landscape of histone modifications in human T cells. Proc. Natl Acad. Sci. USA 103, 15782-15787 (2006).
33. Araki Y, Wang Z, Zang C et al. Genome-wide analysis of histone methylation reveals chromatin state-based regulation of gene transcription and function of memory CD8+ T cells. Immunity 30, 912-925 (2009).
34. Murray K. The occurrence of epsilon-N-methyl lysine in histones. Biochemistry 3, 10-15 (1964).
35. Lehnertz B, Northrop JP, Antignano F et al. Activating and inhibitory functions for the histone lysine methyltransferase G9a in T helper cell differentiation and function. J. Exp. Med. 207, 915-922 (2010).
36. Nakata Y, Brignier AC, Jin S et al. c-Myb Menin GATA-3, and MLL form a dynamic transcription complex that plays a pivotal role in human T helper type 2 cell development. Blood 116, 1280-1290 (2010).
37. Onodera A, Yamashita M, Endo Y et al. STAT6-mediated displacement of polycomb by trithorax complex establishes long-term maintenance of GATA3 expression in T helper type 2 cells. J. Exp. Med. 207, 2493-2506 (2010).
38. Kozuka T, Sugita M, Shetzline S, Gewirtz AM, Nakata Y. c-Myb and GATA-3 cooperatively regulate IL-13 expression via conserved GATA-3 response element and recruit mixed lineage leukemia (MLL) for histone modification of the IL-13 locus. J. Immunol. 187, 5974-5982 (2011).
39. Allan RS, Zueva E, Cammas F et al. An epigenetic silencing pathway controlling T helper 2 cell lineage commitment. Nature 487, 249-253 (2012).
40. He S, Wang J, Kato K et al. Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cells. Blood 119, 1274-1282 (2012).
41. Denton AE, Russ BE, Doherty PC, Rao S, Turner SJ. Differentiation- dependent functional and epigenetic landscapes for cytokine genes in virus-specific CD8+ T cells. Proc. Natl Acad. Sci. USA 108, 15306-15311 (2011).
42. Lu KT, Kanno Y, Cannons JL et al. Functional and epigenetic studies reveal multistep differentiation and plasticity of in vitro-generated and in vivo-derived follicular T helper cells. Immunity 35, 622-632 (2011).
43. Mukasa R Balasubramani A, Lee YK et al. Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity 32, 616-627 (2010).
44. Boyle AP, Davis S, Shulha HP et al. High-resolution mapping and characterization of open chromatin across the genome. Cell 132, 311-322 (2008).
45. Cohen CJ, Crome SQ, MacDonald KG et al. Human Th 1 and Th 17 cells exhibit epigenetic stability at signature cytokine and transcription factor loci. J. Immunol. 187, 5615-5626 (2011).
46. O'Shea JJ, Paul WE. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327, 1098-1102.
47. Stockinger B, Veldhoen M. Differentiation and function of Th 17 T cells. Curr. Opin. Immunol. 19, 281-286 (2007).
48. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25, 821-852 (2007).
49. Bernstein BE, Mikkelsen TS, Xie X et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315-326 (2006).
50. Josefowicz SZ. Regulators of chromatin state and transcription in CD4 T-cell polarization. Immunology 139, 299-308.
51. Lee YK, Turner H, Maynard CL et al. Late developmental plasticity in the T helper 17 lineage. Immunity 30, 92-107 (2009).
52. Segal BM. Th 17 cells in autoimmune demyelinating disease. Semin. Immunopathol. 32, 71-77 (2010).
53. Zhang Y, Sandy AR, Wang J et al. Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease. Blood 117, 299-308 (2011).
54. Carpenter AC, Grainger JR, Xiong Y et al. The transcription factors Thpok and LRF are necessary and partly redundant for T helper cell differentiation. Immunity 37, 622-633 (2012).
55. Zediak VP, Johnnidis JB, Wherry EJ, Berger SL. Cutting edge: persistently open chromatin at effector gene loci in resting memory CD8+ T cells independent of transcriptional status. J. Immunol. 186, 2705-2709 (2011).
56. Pearce EL, Mullen AC, Martins GA et al. Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 302, 1041-1043 (2003).
57. Intlekofer AM, Takemoto N, Wherry EJ et al. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 6, 1236-1244 (2005).
58. Intlekofer AM, Takemoto N, Kao C et al. Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells. J. Exp. Med. 204, 2015-2021 (2007).
59. Joshi NS, Cui W, Chandele A et al. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27, 281-295 (2007).
60. Paley MA, Kroy DC, Odorizzi PM et al. Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection. Science 338, 1220-1225 (2012).
61. Martins G, Calame K. Regulation and functions of Blimp-1 in T and B lymphocytes. Annu. Rev. Immunol. 26, 133-169 (2008).
62. Kallies A, Xin A, Belz GT, Nutt SL. Blimp-1 transcription factor is required for the differentiation of effector CD8(+) T cells and memory responses. Immunity 31, 283-295 (2009).
63. Rutishauser RL, Martins GA, Kalachikov S et al. Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity 31, 296-308 (2009).
64. Shin H, Blackburn SD, Intlekofer AM et al. A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection. Immunity 31, 309-320 (2009).
65. Cannarile MA, Lind NA, Rivera R et al. Transcriptional regulator Id 2 mediates CD8+ T cell immunity. Nat. Immunol. 7, 1317-1325 (2006).
66. Kallies A. Distinct regulation of effector and memory T-cell differentiation. Immunol. Cell Biol. 86, 325-332 (2008).
67. Rea S, Eisenhaber F, O'Carroll D et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406, 593-599 (2000).
68. Greer EL, Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat. Rev. Genet. 13, 343-357 (2012).
69. Feng Q, Wang H, Ng HH et al. Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain. Curr. Biol. 12, 1052-1058 (2002).
70. Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 21, 381-395 (2011).
71. Schuettengruber B, Chourrout D, Vervoort M, Leblanc B, Cavalli G. Genome regulation by polycomb and trithorax proteins. Cell 128, 735-745 (2007).
72. Margueron R, Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature 469, 343-349 (2011).
73. Black JC, Van Rechem C, Whetstine JR. Histone lysine methylation dynamics: establishment, regulation, and biological impact. Mol. Cell 48, 491-507 (2012).
74. Boyer LA, Plath K, Zeitlinger J et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441, 349-353 (2006).
75. Bracken AP, Kleine-Kohlbrecher D, Dietrich N et al. The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev. 21, 525-530 (2007).
76. Ringrose L, Paro R. Polycomb/Trithorax response elements and epigenetic memory of cell identity. Development 134, 223-232 (2007).
77. Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev. 20, 1123-1136 (2006).
78. Ringrose L, Paro R. Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu. Rev. Genet. 38, 413-443 (2004).
79. Bannister AJ, Zegerman P, Partridge JF et al. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410, 120-124 (2001).
80. Lachner M, O'Carroll D, Rea S, Mechtler K, Jenuwein T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410, 116-120 (2001).
81. Tachibana M, Sugimoto K, Fukushima T, Shinkai Y. Set domain-containing protein G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3. J. Biol. Chem. 276, 25309-25317 (2001).
82. Tachibana M, Sugimoto K, Nozaki M et al. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 16, 1779-1791 (2002).
83. Murphy E, Shibuya K, Hosken N et al. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J. Exp. Med. 183, 901-913 (1996).
84. Grogan JL, Mohrs M, Harmon B, Lacy DA, Sedat JW, Locksley RM. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 14, 205-215 (2001).
85. Hagen EA, Stern H, Porter D et al. High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation. Clin. Infect. Dis. 36, 9-15 (2003).
86. Muntean AG, Hess JL. The pathogenesis of mixed-lineage leukemia. Annu. Rev. Pathol. 7, 283-301 (2012).
87. Bantignies F, Cavalli G. Cellular memory and dynamic regulation of polycomb group proteins. Curr. Opin. Cell Biol. 18, 275-283 (2006).
88. Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M. The oncogene and Polycomb-group gene BMI-1 regulates cell proliferation and senescence through the INK4a locus. Nature 397, 164-168 (1999).
89. Su IH, Dobenecker MW, Dickinson E et al. Polycomb group protein EZH 2 controls actin polymerization and cell signaling. Cell 121, 425-436 (2005).
90. Hod-Dvorai R, Jacob E, Boyko Y, Avni O. The binding activity of Mel-18 at the IL 17a promoter is regulated by the integrated signals of the TCR and polarizing cytokines. Eur. J. Immunol. 41, 2424-2435 (2011).
91. Jacob E, Hod-Dvorai R, Ben-Mordechai OL, Boyko Y, Avni O. Dual function of polycomb group proteins in differentiated murine T helper (CD4+) cells. J. Mol. Signal. 6, 5 (2011).
92. Kaech SM, Hemby S, Kersh E, Ahmed R. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111, 837-851 (2002).
93. Kaech SM, Wherry EJ Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. Immunity 27, 393-405 (2007).
94. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4, 1191-1198 (2003).
95. Wherry EJ, Teichgräber V, Becker TC et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4, 225-234 (2003).
96. Kaech SM, Wherry EJ, Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2, 251-262 (2002).
97. Wherry EJ, Ahmed R. Memory CD8 T-cell differentiation during viral infection. J. Virol. 78, 5535-5545 (2004).
98. Ahmed R, Bevan MJ, Reiner SL, Fearon DT. The precursors of memory: models and controversies. Nat. Rev. Immunol. 9, 662-668 (2009).
99. Fearon DT, Manders P, Wagner SD. Arrested differentiation, the self-renewing memory lymphocyte, and vaccination. Science 293, 248-250 (2001).
100. Sarkar S, Kalia V, Haining WN, Konieczny BT, Subramaniam S, Ahmed R. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J. Exp. Med. 205, 625-640 (2008).
101. Masopust D, Kaech SM, Wherry EJ, Ahmed R. The role of programming in memory T-cell development. Curr. Opin. Immunol. 16, 217-225 (2004).
102. Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 290, 92-97 (2000).
103. Williams MA, Bevan MJ. Effector and memory CTL differentiation. Annu. Rev. Immunol. 25, 171-192 (2007).
104. Kato K, Cui S, Kuick R et al. Identification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8+ T cells mediating graft-versus-host disease. Biol. Blood Marrow Transplant. 16, 751-771 (2010).
105. Suzuki A, Iwamura C, Shinoda K et al. Polycomb group gene product Ring 1B regulates Th 2-driven airway inflammation through the inhibition of Bim-mediated apoptosis of effector Th 2 cells in the lung. J. Immunol. 184, 4510-4520 (2010).
106. Raaphorst FM, Otte AP, van Kemenade FJ et al. Distinct BMI-1 and EZH2 expression patterns in thymocytes and mature T cells suggest a role for polycomb genes in human T cell differentiation. J. Immunol. 166, 5925-5934 (2001).
107. van Kemenade FJ, Raaphorst FM, Blokzijl T et al. Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood 97, 3896-3901 (2001).
108. Simon JA, Lange CA. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat. Res. 647, 21-29 (2008).
109. Liu J, Chen J, Song S et al. BMI 1 regulates mitochondrial function and the DNA damage response pathway. Nature 459, 387-392 (2009).
110. Viré E, Brenner C, Deplus R et al. The polycomb group protein EZH2 directly controls DNA methylation. Nature 439, 871-874 (2006).
111. Simon C, Chagraoui J, Krosl J et al. A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia. Genes Dev. 26, 651-656 (2012).
112. Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes Dev. 25, 1010-1022.
113. Weng NP, Araki Y, Subedi K. The molecular basis of the memory T cell response: differential gene expression and its epigenetic regulation. Nat. Rev. Immunol. 12, 306-315.
114. Youngblood B, Hale JS, Ahmed R. T-cell memory differentiation: insights from transcriptional signatures and epigenetics. Immunology 139, 277-284.
115. Lewis MD, Miller SA, Miazgowicz MM, Beima KM, Weinmann AS. T-bet's ability to regulate individual target genes requires the conserved T-box domain to recruit histone methyltransferase activity and a separate family member-specific transactivation domain. Mol. Cell Biol. 27, 8510-8521 (2007).
116. Miller SA, Huang AC, Miazgowicz MM, Brassil MM, Weinmann AS. Coordinated but physically separable interaction with H3K27-demethylase and H3K4-methyltransferase activities are required for T-box protein-mediated activation of developmental gene expression. Genes Dev. 22, 2980-2993 (2008).
117. Kaplan MH, Sun YL, Hoey T, Grusby MJ. Impaired IL-12 responses and enhanced development of Th 2 cells in Stat 4-deficient mice. Nature 382, 174-177 (1996).
118. Oestreich KJ, Weinmann AS. Transcriptional mechanisms that regulate T helper 1 cell differentiation. Curr. Opin. Immunol. 24, 191-195 (2012).
119. Zhu J, Min B, Hu-Li J et al. Conditional deletion of Gata 3 shows its essential function in T(h)1-T(h)2 responses. Nat. Immunol. 5, 1157-1165 (2004).
120. Ho IC, Pai SY. GATA-3 - not just for Th 2 cells anymore. Cell Mol. Immunol. 4, 15-29 (2007).
121. Ouyang W, Ranganath SH, Weindel K et al. Inhibition of Th 1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 9, 745-755 (1998).
122. Usui T, Nishikomori R, Kitani A, Strober W. GATA-3 suppresses Th 1 development by downregulation of Stat 4 and not through effects on IL-12Rbeta 2 chain or T-bet. Immunity 18, 415-428 (2003).
123. Hwang ES, Szabo SJ, Schwartzberg PL, Glimcher LH. T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science 307, 430-433 (2005).
124. Yagi R, Zhu J., Paul WE. An updated view on transcription factor GATA3-mediated regulation of Th 1 and Th 2 cell differentiation. Int. Immunol. 23, 415-420 (2011).
125. Chen GY, Osada H, Santamaria-Babi LF, Kannagi R. Interaction of GATA-3/T-bet transcription factors regulates expression of sialyl Lewis X homing receptors on Th 1/Th 2 lymphocytes. Proc. Natl Acad. Sci. USA 103, 16894-16899 (2006).
126. Cuddapah S, Barski A, Zhao K. Epigenomics of T cell activation, differentiation, and memory. Curr. Opin. Immunol. 22, 341-347 (2010).
127. Grembecka J, He S, Shi A, Purohit T et al. Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia. Nat. Chem. Biol. 8, 277-284 (2012).
128. Else KJ, Finkelman FD, Maliszewski CR, Grencis RK. Cytokine-mediated regulation of chronic intestinal helminth infection. J. Exp. Med. 179, 347-351 (1994).
129. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet 373, 1550-1561 (2009).
130. McCabe MT, Ott HM, Ganji G et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature 492, 108-112 (2012).
131. Knutson SK, Wigle TJ, Warholic NM et al. A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells. Nat. Chem. Biol. 8, 890-896 (2012).
132. Qi W, Chan H, Teng L et al. Selective inhibition of Ezh 2 by a small molecule inhibitor blocks tumor cells proliferation. Proc. Natl Acad. Sci. USA 109, 21360-21365 (2012).
133. Buchholz VR, Flossdorf M, Hensel I et al. Disparate individual fates compose robust CD8+ T cell immunity. Science 340(6132), 630-635 (2013).
134. Zhang Y, Joe G, Hexner E, Zhu J, Emerson SG. Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease. J. Immunol. 174, 3051-3058 (2005).
135. Zhang Y, Joe G, Hexner E, Zhu J, Emerson SG. Host-reactive CD8+ memory stem cells in graft-versus-host disease. Nat. Med. 11, 1299-1305 (2005).
136. Gattinoni L, Klebanoff CA, Palmer DC et al. Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. J. Clin. Invest. 115, 1616-1626 (2005).
137. Gattinoni L, Lugli E, Ji Y et al. A human memory T cell subset with stem cell-like properties. Nat. Med. 17, 1290-1297 (2011).
138. Gattinoni L, Zhong XS, Palmer DC et al. Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells. Nat. Med. 15, 808-813 (2009).
139. Wang L, Jin Q, Lee JE, Su IH, Ge K. Histone H3K27 methyltransferase Ezh 2 represses Wnt genes to facilitate adipogenesis. Proc. Natl Acad. Sci. USA 107, 7317-7322 (2010).
140. Min J, Zaslavsky A, Fedele G et al. An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB. Nat. Med. 16, 286-294 (2010).